# OnCo record dan-311 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dan-311/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dan-311" ;
  schema:name "DAN-311"@en ;
  schema:description "DAN-311 is an experimental targeted high-capacity drug conjugate from Dantari, in preclinical development for HER2-positive breast cancer and HER2-low breast cancer; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/dan-311/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/dantari-launches-with-47m-to-make-better-adcs> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Targeted high-capacity drug conjugate" ;
  onco:companies <https://onco.cc/companies/dantari/> .